Food-Derived Limosilactobacillus fermentum GR-3 Enhances Anti–PD-1 Immunotherapy Efficacy

Wei Xiang, Qi Yang, Jing Ji, Hui Qiao, Aman Khan, El-Sayed Salama, Chunlan Mao, Ying Wu, Xiangkai Li · 2026

Read Food-Derived Limosilactobacillus fermentum GR-3 Enhances Anti–PD-1 Immunotherapy Efficacy by Wei Xiang, Qi Yang, Jing Ji, Hui Qiao, Aman Khan, El-Sayed Salama, Chunlan Mao, Ying Wu, Xiangkai Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13518518.txt.

Description

Wei Xiang and co-authors present a 2026 study on a food-derived probiotic that helps cancer immunotherapy work harder. Checkpoint drugs free the immune system, but many patients respond weakly. The team picked a hardy Lactobacillus strain from food, chosen for surviving the gut and calming oxidation, and fed it alongside anti-PD-1 therapy in mice.

In a mouse colon cancer model, the combo shrank tumors far more than the drug alone, with about 52 percent less volume than untreated controls. Treated mice also lost less weight during therapy. Inside the tumors, dendritic cells matured in greater numbers. Macrophages tilted toward the attacking M1 type and away from the soothing M2 type. The strain looks like a rational partner for checkpoint care.

Catalog record

CREATORWei Xiang, Qi Yang, Jing Ji, Hui Qiao, Aman Khan, El-Sayed Salama, Chunlan Mao, Ying Wu, Xiangkai Li
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13518518

Browse the full library · About the Tower of Babel